Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

by Arellano Jorge, Taipale Kaisa, Wood Eifiona, Camps Carlos, Valladares Amparo, Asukai Yumi, Cassinello Alejo, Sacristán José, Dilla Tatiana
Published 2010-01-01